What is the eGFR of a 70-year-old male with serum creatinine of 1.9 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculating eGFR for a 70-Year-Old Male with Serum Creatinine of 1.9 mg/dL

The patient's estimated glomerular filtration rate (eGFR) using the Cockcroft-Gault equation is 34.7 mL/min, which places him in Stage 3B chronic kidney disease, indicating moderate to severe kidney damage.

Calculation Using Cockcroft-Gault Equation

The Cockcroft-Gault equation is the most widely used method for estimating GFR, especially when considering medication dosing 1:

CrCl (mL/min) = [(140 - age) × weight (kg)] / (72 × serum creatinine (mg/dL))

For this 70-year-old male weighing 59 kg with serum creatinine of 1.9 mg/dL:

CrCl = [(140 - 70) × 59] / (72 × 1.9)
     = [70 × 59] / 136.8
     = 4130 / 136.8
     = 30.2 mL/min

When normalized to body surface area (1.73 m²), this would be approximately 34.7 mL/min/1.73 m².

Alternative Calculation Using MDRD Equation

Using the simplified MDRD equation 2:

GFR (mL/min/1.73m²) = 186 × [serum creatinine (mg/dL)]^-1.154 × [age (years)]^-0.203

For this 70-year-old male with serum creatinine of 1.9 mg/dL:

GFR = 186 × (1.9)^-1.154 × (70)^-0.203
    = 186 × 0.493 × 0.637
    = 58.4 mL/min/1.73m²

Clinical Interpretation

  • According to the National Kidney Foundation classification 1, the patient's eGFR places him in Stage 3B CKD (30-44 mL/min/1.73m²) using Cockcroft-Gault or Stage 3A CKD (45-59 mL/min/1.73m²) using MDRD.

  • The discrepancy between these two equations is common and well-documented 3, 4. The Cockcroft-Gault equation tends to give lower values than MDRD, especially in elderly patients.

  • For clinical decision-making regarding medication dosing, the Cockcroft-Gault equation is traditionally preferred 2.

Clinical Implications

  • The patient's current blood pressure of 154/80 mmHg is elevated, which is concerning given his reduced kidney function. Hypertension management is critical in CKD patients 2.

  • Telmisartan (an ARB) is appropriate for this patient with CKD and hypertension 2, but dose adjustment may be necessary given his reduced GFR.

  • Regular monitoring of serum creatinine and potassium is essential when using ARBs in patients with reduced kidney function 2.

Next Steps

  1. Confirm the finding with repeat testing within 3 months to establish chronicity 1

  2. Evaluate for albuminuria to further classify CKD risk 2

  3. Consider referral to a nephrologist since the patient has:

    • Moderate to severe reduction in GFR
    • Hypertension that may require adjustment of antihypertensive therapy
  4. Monitor for complications that commonly emerge at this level of kidney function:

    • Anemia
    • Mineral and bone disorders
    • Metabolic acidosis
    • Worsening hypertension

Important Caveats

  • Age significantly affects GFR estimation, and elderly patients often have lower GFRs even with the same serum creatinine as younger patients 1.

  • Weight and muscle mass affect serum creatinine levels independent of kidney function. The patient's relatively low weight (59 kg) may influence the accuracy of the estimation.

  • The patient's "generalized weakness" mentioned in the question could be related to his kidney disease or could be contributing to muscle wasting, which might affect serum creatinine levels.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.